Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155216 · ClinicalTrials.gov registry record · NA
A Guided Meditation Program in Patients Undergoing Dialysis
A NA study, sponsored by The Rogosin Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04155216 is a NA study that has completed, run by The Rogosin Institute. The registered enrollment target is 10 participants.
The verdict
NCT04155216, a NA study, has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an open-label, single center, non-randomized, single-arm pilot study to determine the ability of a Relaxation and Guided Imagery Program for its ability to induce a reduction in anxiety in subjects undergoing hemodialysis for End Stage Renal Disease (ESRD). Measures will evaluate the program's ability to impact anxiety, with secondary analysis of headaches, insomnia, fatigue, and pain. Subjects will be administered questionnaires at the study start and study end. Intervention will involve listening to a pre-recorded guided relaxation and imagery during regularly-scheduled dialysis sessions for four weeks.
Interventions
- BEHAVIORAL Relaxation and guided imagery program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2020-10-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155216
The ClinicalTrials.gov registry entry for NCT04155216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relaxation and guided imagery program is the first listed.
NCT04155216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04155216 about?
NCT04155216 is a clinical study titled "A Guided Meditation Program in Patients Undergoing Dialysis". This is an open-label, single center, non-randomized, single-arm pilot study to determine the ability of a Relaxation and Guided Imagery Program for its ability to induce a reduction in anxiety in subjects undergoing hemodialysis for End Stage Renal Disease (ESRD). Measures will evaluate the program...
What is the current status of trial NCT04155216?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-06. Estimated completion is 2020-10-07.
What interventions are being tested in trial NCT04155216?
The interventions under investigation include: Relaxation and guided imagery program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04155216?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.